Dr. Lau Lit Fui joined Lee’s Pharmaceutical Holdings Ltd. in 2012 and is currently President and Chief Scientific Officer of Zhaoke Ophthalmology. He is primarily responsible for overseeing the overall scientific functions and business development in overseas territories for the company.
Dr. Lau has 26 years of extensive multi-faceted experiences in the drug industry that have made him a fully integrated drug developer. His experience covers early drug discovery, preclinical development, clinical trials, registration, sales and marketing, business development, fund raising, merger and acquisition and IPO.
Prior to his work at Lee’s Pharm and Zhaoke Ophthalmology, Dr. Lau spent 14 years at multinational companies including Pfizer Global R&D (USA) and GlaxoSmithKline R&D Center (China). Over the years his outstanding achievements and contributions have been recognized and reflected by the awards that he has received from his employers, business partners and governments.
Dr. Lau obtained both his B.Sc. degree and M.Phil. from The Chinese University of Hong Kong, where he was awarded the Wong Siew Chan Scholarship. He obtained his Ph.D. from the University of Connecticut Health Center and his postdoctoral fellowship at the School of Medicine of John Hopkins University in the United States.